REFRACTORY TRANSFORMED B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for REFRACTORY TRANSFORMED B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY TRANSFORMED B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY TRANSFORMED B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Punch combo trial aims to tame aggressive cancer
Disease control Recruiting nowThis study is testing a two-part treatment for Richter's syndrome, an aggressive cancer that develops from a slower-growing blood cancer. It combines a daily pill (zanubrutinib) with a one-time infusion of specially modified immune cells (CAR-T therapy) to attack the cancer. The …
Matched conditions: REFRACTORY TRANSFORMED B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Aseel Alsouqi • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New CAR-T therapy trial targets Tough-to-Treat HIV-Related cancers
Disease control Recruiting nowThis early-stage study is testing a personalized immune therapy called axicabtagene ciloleucel (a type of CAR-T) for people with HIV who have an aggressive form of B-cell lymphoma that has returned or not responded to prior treatments. The main goals are to check if the treatment…
Matched conditions: REFRACTORY TRANSFORMED B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC